SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-15-005315
Filing Date
2015-02-11
Accepted
2015-02-11 10:41:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G/A 64179
  Complete submission text file 0001140361-15-005315.txt   65646
Mailing Address 399 PARK AVE NEW YORK NY 10022
Business Address 399 PARK AVE NEW YORK NY 10022 2127563300
FIRST MANHATTAN CO (Filed by) CIK: 0000728083 (see all company filings)

IRS No.: 131957714 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Subject) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83422 | Film No.: 15597396
SIC: 2834 Pharmaceutical Preparations